搜索筛选:
搜索耗时0.3819秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
发布年度:
[会议论文] 作者：Nan-Ya Wang,Heng-Jun Zhao,Jiu-Wei Cui,Wei Li,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
[会议论文] 作者：Nan-Ya Wang,Heng-Jun Zhao,Jiu-Wei Cui,Wei Li,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective.: To observe the effect and security of the combination therapy of sorafenib and radiofrequency ablation (RFA) for advanced HCC.Methods: Twenty-four advanced HCC patients treated with sorafe...
First-line atezolizumab plus chemotherapy in treatment of extensive small cell lung cancer:a cost-ef
[期刊论文] 作者：Ling-Yu Li,Hong Wang,Xiao Chen,Wen-Qian Li,Jiu-Wei Cui,
来源：中华医学杂志（英文版） 年份：2019
Background: IMpower 133 trial first confirmed the efficacy and safety of adding atezolizumab or placebo to first-line treatment with chemotherapy in patients wi...
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adeno
[期刊论文] 作者：Ri-Lan Bai,Nan-Ya Wang,Ling-Ling Zhao,Yong-Fei Zhang,Jiu-Wei Cui,
来源：国际肝胆胰疾病杂志（英文版） 年份：2022
Pancreatic ductal adenocarcinoma (PDAC) is a common cause of cancer-related death, and most patients are with advanced disease when diagnosed. At present, despite a variety of treatments have been devel- oped for PDAC, few effective treatme......
Bortezomib increases the sensitivity of multiple myeloma cell line U266 cells to yδT cell cytotoxici
[会议论文] 作者：Jiu-Wei Cui,Shan-Shan Hao,Hao-Fan Jin,Chao Niu,Guan-Jun Wang,Wei Li,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Bortezomib increases the sensitivity of multiple myeloma cell line U266 cells to yδT cell cytotoxici
[会议论文] 作者：Jiu-Wei Cui,Shan-Shan Hao,Hao-Fan Jin,Chao Niu,Guan-Jun Wang,Wei Li,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: This study aims to evaluate the possible synergistic effects between γδT cells and bortezomib, as well as to determine the underlying mechanism.Methods: The proliferation of U266 cells [mul...
Combination of radiofrequency ablation and cellular immunotherapy reduces the relapse risk of patien
[会议论文] 作者：Guan-Jun Wang,Jiu-Wei Cui,Wei Li,Hao-Fan Jin,Nan-YaWang,Heng-Jun Zhao,Chao Niu,Hua He,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Combination of radiofrequency ablation and cellular immunotherapy reduces the relapse risk of patien
[会议论文] 作者：Guan-Jun Wang,Jiu-Wei Cui,Wei Li,Hao-Fan Jin,Nan-YaWang,Heng-Jun Zhao,Chao Niu,Hua He,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: To investigate the efficiency and safety of the sequential combined application of natural killer (NK), γδT,and cytokine-induced killer (CIK) cells in patients with HCC after radiofrequency...
[期刊论文] 作者：Chen,Yu-Guang Zhao,Xu Wang,Ke-Wei Ma,Hui-Min Tian,Fu-Jun Han,Zi-Ling Liu,Lei Yang,Wei Li,Fei Gai,Jiu-Wei Cui,
来源：中华医学杂志英文版 年份：2021
Background::Circulating tumor DNA (ctDNA) is a promising biomarker for non-invasive epidermal growth factor receptor mutations (n EGFRm) detection in lung cancer patients, but existing methods have limitations in sensitivity and availa......
相关搜索：
